By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement with Merck to conduct a diabetes biomarker discovery research project.

The collaboration will use Ezose's GlycanMap platform to identify changes in glycan patterns on post-translationally modified proteins from human subjects. Ezose did not disclose financial or other terms of the agreement but said that it builds on a series of collaborative studies previously conducted with the New Jersey-based drug giant.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.